...therapy with antibodies against the Rh-D red blood cell antigen). One alternative therapy is the Prosorba...

...make Fresenius and its Fresenius HemoCare Inc. subsidiary (Redmond, Wash.) exclusive global distributors of CYPB's Prosorba...

...CYPB partner Fresenius HemoCare launched in Europe CYPB's Prosorba protein A matrix plasmapheresis column to treat...

...CYPB and partner Fresenius HemoCare (Bad Homburg, Germany) launched in Europe CYPB's Prosorba protein A matrix...

...Canada granted marketing approval for Prosorba to treat rheumatoid arthritis. Medexus Inc. (Toronto, Ontario) will market...
...Prosorba column to treat rheumatoid arthritis (RA). Cypress Bioscience Inc. (CYPB), San Diego, Calif. Product: Prosorba...

...CYPB said partner Fresenius HemoCare (Bad Homburg, Germany) received the CE Mark for CYPB's Prosorba protein...

...Prosorba column in Canada and will pay CYPB the lesser of the pre-determined percentage of Prosorba's...
...transfer price. Medexus also will conduct a trial in Canada for Canadian marketing approval of Prosorba...
...said the trial will partially fulfill a post-marketing study required by the FDA, which approved Prosorba...

...Rheumatism previously reported data from its 109-patient Phase III study in which 31.9 percent of Prosorba-treated...
...p=0.019) (see BioCentury Extra, Jan. 13, 1998). Cypress Bioscience Inc. (CYPB), San Diego, Calif. Product: Prosorba...

...15 patients with RA refractory to disease-modifying anti-rheumatic drugs (DMARDs). Patients in the study received Prosorba...
...after 20 weeks (8 weeks post treatment). Cypress Bioscience Inc. (CYPB), San Diego, Calif. Product: Prosorba...

..."strong buy" and a $6 price target. He said that increased awareness of CYPB's approved Prosorba...